We are excited to announce that Eagle IP will be exhibiting at the BIP Asia Forum 2024 again! Visit us at our booth 1C-C15 in Hall 1B-C at the Hong Kong Convention and Exhibition Centre (HKCEC) on December 5th and 6th (Thursday-Friday) 2024.

The BIP Asia Forum brings together IP professionals and business leaders from around the globe to discuss the latest trends in intellectual property and explore business collaboration opportunities. 

For more information and to register, please visit: BIP Asia Forum.

We look forward to seeing you there! 

Our Past Events

Dr. Jacqueline Lui, Ms. Pauli Wong, and Mr. Eddie Ho Named Patent Stars by ManagingIP

13 June 2025

Eagle IP Ranked Among Top Tier Firms in IAM Patent 1000

12 June 2025

Jennifer Che from Eagle IP to Attend BIO 2025 in Boston!

11 June 2025

Insights from HKSTP Market Discovery - BIO Connect

28 May 2025

HKMHDIA Medical Fair Forum

27 May 2025

Celebrating Innovation at the Asia Summit for Global Health

26 May 2025

Recommended Insights

Why Do Examiners Fail to Recognize the Importance of my “Parameter Features”?

28 May 2025
The Impact of Parameter Features on Inventiveness ”Parameter features” – numerical or mathematical expressions that define the quantity or physical properties of a subject – frequently appear as technical features within a claim. Often described as numerical ranges or measurements, they frequently play a critical role in addressing technical problems. However, in practice, Examiners and […]
Read more >

A More Detailed Overview of China’s Patent Term Extension (PTE) System

17 June 2024
Although PTE has been in the Chinese Patent Law since the 4th Amendment of the law came into effect June 1, 2021, we didn’t really know the exact details of how it operated until the Implementation Regulations and Examination Guidelines (“Implementation Regulations”) were finally released in December 2023. New Rules 77-84 in the Implementation Regulations […]
Read more >

Breaking News: China passes Fourth Amendment to the Chinese Patent Law

19 October 2020
After 12 years, the Fourth Amendment to the Chinese Patent Law has passed and will be in effect on 1 Jun 2021. After years of multiple draft amendments that moved in various directions, we FINALLY have some clarity on what patent protection is going to look like in China in the coming future. Many of […]
Read more >

RNAi Patent Success in China: Overcoming “Comprising” Claim Challenges

10 March 2025
An Update on Sufficiency and Inventiveness of RNAi Patents in China RNAi is a fast-developing technology that has gained traction in the pharmaceutical industry as a promising therapeutic agent. It is important to follow closely RNAi patent proceedings to learn how different examination boards and courts understand and handle these new technologies. The first-ever invalidation […]
Read more >
Top crossarrow-right